Current status and future prospects of the global lymphatic filariasis programme

Current Opinion in Infectious Diseases

Volumn 14, Issue 2, 2001, Pages 155-159

  Molyneux, D H ^a   Taylor, M J ^a  

^a LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALBENDAZOLE; DOXYCYCLINE; IVERMECTIN; OXYTETRACYCLINE; RIFAMPICIN; TETRACYCLINE;

BRUGIA PAHANGI; CLINICAL TRIAL; ELEPHANTIASIS; ENDEMIC DISEASE; FILARIASIS; HEALTH CARE COST; HEALTH PROGRAM; HUMAN; HYDROCELE; INFECTION CONTROL; INFLAMMATION; INTERNATIONAL COOPERATION; LOA LOA; LYMPHEDEMA; MOSQUITO; ONCHOCERCA VOLVULUS; ONCHOCERCIASIS; REVIEW; SOCIOECONOMICS; WOLBACHIA; WORLD HEALTH ORGANIZATION; WUCHERERIA BANCROFTI;

EID: 0035086186     PISSN: 09517375     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001432-200104000-00008     Document Type: Review

References (36)

1. Lymphatic filariasis: Setting the scene for elimination
2. Onchocerciasis and Chagas' disease control: The evolution of control via applied research through changing development scenarios
3. Can vector control play a useful supplementary role against bancroftian filariasis?
4. Programmatic goals and approaches to onchocerciasis
5. Onchocerciasis control strategies
6. Mapping and estimating the population at risk from lymphatic filariasis in Africa
7. Field evaluation of a rapid-format kit for the diagnosis of bancroftian filariasis in Egypt
8. Evaluation of the ICT whole blood antigen card test to detect infection due to nocturnally periodic Wuchereria bancrofti in South India
9. Field trial of the ICT filariasis for diagnosis of Wuchereria bancrofti infections in an endemic population of Thailand
10. ICT filariasis test: A new screening test for Bancroftian filariasis
11. Assessment of an immunochromatographic test for rapid lymphatic filariasis diagnosis
12. Development of rapid assessment procedures for the delimitation of lymphatic filariasis-endemic areas
13. Hydrocelectomy: A proxy for hydrocele prevalence in coastal Kenya
14. Lymphatic filariasis in the Philippines
15. Bancroftian filariasis in Madagascar: A persistent endemic disease
16. Screening of army soldiers for Wuchereria bancrofti infection in the metropolitan Recife region, Brazil: Implications for epidemiological surveillance
17. Comparative epidemiological studies on lymphatic filariasis, between tribal and non-tribal populations of Bankura district, West Bengal, India
18. Satellite mapping of Loa loa prevalence in relation to ivermectin use in west and central Africa
19. The economic burden of lymphatic filariasis in India
20. The impact of lymphatic filariasis on labour inputs in southern India: Results of a multi-site study
21. Lymphatic filariasis: Economic aspects of the disease and programmes for its elimination
22. Effect of lymphatic filariasis on school children
23. Endosymbiotic bacteria in worms as targets for a novel chemotherapy in filariasis
24. Wolbachia bacteria of filarial nematodes: A target for control?
25. Wolbachia bacteria of filarial nematodes in the pathogenesis of disease and as a target for control
26. Macrofilaricidal activity of tetracycline against the filarial nematode Onchocerca ochengi: Elimination of Wolbachia precedes worm death and suggests a dependent relationship
27. Antibiotics and Wolbachia in filarial nematodes: Antifilarial activity of rifampicin, oxytetracycline and chloramphenicol against Onchocerca gutturosa, Onchocerca lienalis and Brugia pahangi
28. Inflammatory responses induced by the filarial nematode Brugia malayi are mediated by lipopolysaccharide-like activity from endosymbiotic Wolbachia bacteria
29. Lipopolysaccharide-like molecules derived from Wolbachia endobacteria of the filaria Onchocerca volvulus are candidate mediators in the sequence of inflammatory and antiinflammatory responses of human monocytes
30. Serious reactions after mass treatment of onchocerciasis with ivermectin in an area endemic for Loa loa infection
31. Strong association of interleukin-6 and lipopolysaccharide-binding protein with severity of adverse reactions after diethylcarbamazine treatment of microfilaremic patients
32. Lymphatic filariasis in Ghana: From research to control
33. The role of NGDOs in disease elimination programmes: The lessons from onchocerciasis control
34. New insights into the natural history and pathology of bancroftian filariasis: Implications for clinical management and filariasis control programmes
35. The global programme to eliminate lymphatic filariasis
36. The role of albendazole in programmes to eliminate lymphatic filariasis